SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theravance - THRX -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (69)12/22/2008 2:09:17 PM
From: idos  Respond to of 74
 
They have significantly lowered the tested doses in order to find an optimum safety profile so question is if the loss in efficacy is not too big and will '444 can compete with Salmeterol.